Senate Democrats and the Trump administration are locked in a legal and political battle over the composition of the Advisory Committee on Immunization Practices (ACIP), a key federal panel that influences vaccine policy. Senators Ron Wyden (D-OR) and Maggie Hassan (D-NH) demanded records from Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. regarding his decision to disband and reformulate the ACIP. Meanwhile, the Trump administration is appealing a court ruling that blocked Kennedy’s appointees from serving on the panel.
Part 1: Immediate Action & Core Facts
Senate Democrats launched an investigation into Kennedy’s overhaul of the ACIP, accusing him of replacing independent experts with allies skeptical of vaccines. The administration, however, is urging a federal appeals court to overturn a lower court’s decision that barred Kennedy’s appointees from serving, arguing the panel cannot function without them.
Part 2: Deeper Dive & Context
Background on the ACIP Overhaul
Kennedy, a longtime vaccine skeptic, dissolved the ACIP in 2023 and replaced its members with new appointees. The new panel made several changes, including rolling back recommendations for the hepatitis B vaccine for newborns and altering COVID-19 vaccine guidelines for children. Critics, including the American Academy of Pediatrics, have sued to block these changes.
Legal and Political Fallout
A federal judge ruled in March that Kennedy’s appointment process violated the Federal Advisory Committee Act, blocking 13 of the 15 new members from serving. The Trump administration is now appealing, arguing the ruling prevents the panel from making critical flu vaccine recommendations. The administration is not challenging the judge’s decision to halt changes to childhood vaccine schedules.
Diverse Perspectives
Senate Democrats allege Kennedy’s actions were politically motivated, citing his history of litigation against vaccine manufacturers. Kennedy has maintained the changes were made in consultation with the White House. The administration argues the court’s ruling has crippled the panel’s ability to respond to public health threats.